Study reveals how estrogen exerts its anti-diabetic effects

The quintessential female sex hormone estrogen stimulates cells that line blood vessels to deliver insulin to muscles, lowering blood sugar and protecting against Type 2 diabetes, UT Southwestern Medical Center researchers report. The findings, published in Nature Communications, could eventually lead to new therapies for Type 2 diabetes, a disease that affects hundreds of millions of people around the globe and continues to grow more prevalent.

Primary care intervention reduces hypoglycemia risk from type 2 diabetes overtreatment in older adults

A newly published quality improvement study shows how a simple intervention by health care providers reduced the number of older adult patients with type 2 diabetes at risk for hypoglycemia (low blood sugar) by almost 50% and led to de-escalation of diabetes medications that cause hypoglycemia in 20% of patients.

UC San Diego Health Ranks No. 1 in San Diego, Makes National Honor Roll

U.S. News & World Report ranks 10 medical and surgical specialties at UC San Diego Health among the nation’s best.

Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best

Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.

Single hospital study finds transgender teenagers rarely choose to discontinue hormone therapy

A three-year-long retrospective cohort study of a single Atlanta hospital’s patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Transgender people seen in the ER much more likely than cisgender people to be admitted to hospital

Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are much more likely to be admitted to the hospital once they visit the ER, according to a study being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Study finds “robotic pill” can safely deliver injectable osteoporosis drug

A proven and effective medication for osteoporosis, which is currently only available as an injection, can be administered orally using a novel “robotic pill,” according to a study presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Endocrine-disrupting chemicals may raise risk of cognitive disorders in future generations, animal study finds

Adverse cognitive effects linked to polychlorinated biphenyls (PCBs) exposure, a type of endocrine-disrupting chemical (EDC), have the potential to be passed down through generations, according to an animal study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Low food security linked to metabolic syndrome in reproductive-aged Latinx females

Not having reliable access to food has a significant relationship with metabolic syndrome, a condition that increases risk for diseases such as diabetes and heart disease, in Latinx females of reproductive age, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

CGM alarms often not set to alert children with diabetes to harmful blood glucose fluctuations

Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, according to a study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. This variability makes the monitors less useful in tracking glucose levels.

Statin alternative lowers risk of cardiac events as well as cholesterol levels

A medication called bempedoic acid reduced the risk of cardiac events as well as statins and may offer an alternative to the popular cholesterol-reducing medications, according to industry-supported research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill.

ENDO 2023 press conferences to highlight emerging technology and diabetes research

Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society’s ENDO 2023 news conferences June 15-18.

Niraula wins 2023 Endocrine Images Art Competition

Anzela Niraula, Ph.D., of the University of Washington in Seattle, won the Endocrine Society’s 2023 Endocrine Images Art Competition for her image of the microglia mandala. This contest celebrates the beauty of endocrine science, and entries were judged based on aesthetic value and significance to endocrine research.

Response to hormone therapy predicts radiation resistance in ER+ breast cancer

How estrogen receptor-positive (ER+) breast cancer responds to hormone therapy may hold keys to understanding how it will respond to radiation therapy, and an experimental drug that increases the effectiveness of hormone therapy also overcomes radiation resistance in breast cancer, a study by UT Southwestern Medical Center researchers shows.